Abstract Acute kidney injury (AKI) because of bilateral renal infiltration is an uncommon presentation of diffuse large B-cell lymphoma (DLBCL). A 52-year-old man presented to our institution with AKI and complaints of fatigue. Ultrasonography revealed a large, 15 cm granulomatous mass arising from the bilateral kidneys. The mass was biopsied laparoscopically, and histopathological analysis revealed evidence of DLBCL. The patient subsequently underwent R-CHOP therapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Chemotherapy resulted in a rapid decrease in mass size and improvement in kidney function. However, after five courses of R-CHOP, relapse was observed in the central nervous system, and the patient died 220 days after the initial onset of AKI. Post-mortem analysis of renal tissue confirmed the initial diagnosis of DLBCL-associated renal infiltration. To our knowledge, this is the first report of DLBCL presenting as bilateral renal infiltration and AKI.
Introduction
Malignant lymphoma (ML) can develop in any extralymphatic organ. Renal injury is a common and wellcharacterized complication of lymphoma [1] . In general, lymphoma-induced renal injury occurs because of disseminated renal infiltration, mechanical compression by the tumor, glomerular and tubular damage induced by tumor-associated proteins, and tumor lysis syndrome during chemotherapy treatment [2, 3] . However, infiltration of the bilateral kidneys is rare [4] . Given that there is no lymph tissue within the renal interstitium, the origin of ML cells confined to the kidneys is unknown [2, 3] .
Here, we report a case of acute kidney injury (AKI) because of diffuse large B-cell lymphoma (DLBCL) infiltration of the bilateral kidneys, diagnosed by renal biopsy. The diagnosis was confirmed by three separate renal biopsies (at the time of diagnosis, after chemotherapy, and during autopsy).
Case
A 52-year-old man presented to our hospital with weight gain, anuria, and fatigue. Laboratory tests revealed severe kidney injury (Table 1) . Of significance, the past medical history of the patient showed the occurrence of gastric cancer, and he had been followed annually with laboratory testing and computed tomography (CT). His renal function was normal at 1 year prior to presentation. Ultrasonography (US), CT, and magnetic resonance imaging (MRI) demonstrated notably enlarged kidneys (Fig. 1a-c) . Malignant lymphoma was suspected as the cause of both AKI and kidney enlargement. Fludeoxyglucose-positron emission tomography revealed significant uptake in the bilateral kidneys and interior pelvis (Fig. 1d) . To avoid the risk of excessive bleeding because of needle puncture, renal biopsy was performed laparoscopically. Histopathologic analysis of the sample showed massive, diffuse interstitial infiltration with large atypical lymphocytes positive for CD20, CD79a, CD10, and multiple myeloma oncogene 1, and bcl-6-positive B cells. Glomeruli were grossly normal (Fig. 2a) . Based on these findings, the patient was diagnosed with DLBCL, and began R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) shortly thereafter. Tumor lysis syndrome occurred upon the initial R-CHOP therapy. For this reason, the patient underwent treatment with continuous hemodiafiltration at the intensive care unit. He required dialysis for 1 month. After initiation of R-CHOP, his kidney size normalized on US (Fig. 3a-d) , his blood tests improved (lactate dehydrogenase and soluble interleukin-2 receptor value), and maintenance dialysis eventually became unnecessary (Fig. 4) . A renal needle biopsy was performed after five courses of R-CHOP, demonstrating resolution of tubulointerstitial lesions and regeneration of renal tubules (Fig. 2b) . However, on day 141, the patient was noted to be unsteady on his feet, prompting a brain MRI that revealed multiple brain metastases (Fig. 5a ). He underwent radiation therapy and high-dose cytarabine therapy (Fig. 4) . On day 191, new disseminated brain and spinal cord lesions were observed on MRI (Fig. 5b) . These disseminated lesions enlarged rapidly, leading to elevated central nervous system (CNS) pressure on day 214 (Fig. 5c ). The patient died 220 days after the initial onset of AKI. His kidney size The renal interstitium demonstrated massive, diffuse infiltration with large, atypical lymphocytes, whereas the glomeruli were largely normal in appearance (magnification 9200). Scale bar 100 lm. b PAS stain of the second renal biopsy, obtained after five courses of R-CHOP therapy. The tubulointerstitial lesions resolved, and renal tubules regenerated (magnification 9200). Scale bar 100 lm normalized (Fig. 6a) . Post-mortem examination of the kidneys confirmed inflammatory cell infiltration of the tubulointerstitial regions of the kidney, consisting mainly of small lymphocytes (Fig. 6d) . Multiple brain metastases were observed in the cerebrum and cerebellum, consisting of large (Fig. 6b, c) , CD20-positive lymphocytes (Fig. 6e, f) . Brain metastases were surrounded by areas of bleeding and necrosis (Fig. 6b, c) .
Discussion
Approximately one-third of patients with DLBCL present with renal infiltration on autopsy [4, 5] , although bilateral renal involvement is uncommon. Therefore, AKI because of diffuse, bilateral tubulointerstitial infiltration is a rare initial presentation of lymphoma [6] . The most common effects of renal infiltration in patients with DLBCL include direct effects such as obstruction, infiltration, and rupture of the urinary tract; indirect effects such as hypercalcemia, paraproteinemia, amyloidosis, and glomerulonephritis; treatment-related effects such as radiation fibrosis, uric acid/xanthine/ oxypurinol precipitation or stones; and other effects including sepsis, volume depletion, and autoimmune diseases [7] . In the present case, the initial renal biopsy showed normal glomeruli and diffuse infiltration of lymphoma cells within the renal interstitium. Several normal tubular structures were also observed. Based on these results, we postulated that renal tubules became dysfunctional, leading to a state of 'atubular glomeruli' that resulted in abolition of the nephron units, and AKI [8] . Lymphoma cells directly obstruct, infiltrate, or cause rupture of whole sites of the urinary tubule. It is thought that infiltrated lymphoma cells cause glomerular collapse [9] . There is no lymph tissue within the renal interstitium; hence, the origin of ML cells confined to the kidneys is unknown. Bilateral primary renal lymphoma is often associated with AKI, and patients generally survive for less than 1 year [2, 3] . In many cases, infiltration of lymphoma cells into the kidney is confirmed on post-mortem autopsy. However, in our patient, a definitive diagnosis was made on ante-mortem biopsy. In addition, the therapeutic effect of R-CHOP therapy was observed on a second renal biopsy, and relapse was confirmed on autopsy.
Renal involvement in malignant lymphoma is often a sign of progressive disease [10] . The frequency of renal lesions as extranodal involvement in ML is relatively high in autopsy cases. However, it is difficult to diagnose it before the death of the patient, because renal symptoms, as the initial symptoms, are extremely rare in ML [4] . Patients with non-Hodgkin's lymphoma with renal involvement show rapid improvement in renal function and tumor size with treatment. However, treatment failure is common, as in the present case [11] . DLBCL with renal involvement at 4 Rapid decrease of serum lactate dehydrogenase (LDH) and soluble interleukin-2 receptor (sIL-2R) following initiation of chemotherapy (five courses of R-CHOP: 65 mg rituximab, 1300 mg cyclophosphamide, 70 mg doxorubicin, 2 mg vincristine, and 100 mg prednisone). He was treated by radiation therapy from days 146 to 189 (whole-brain radiation: total 37.8 Gy; localized radiation: total 17.4 Gy). Renal biopsy was performed at day 12 and day 126 before and after R-CHOP therapy. We injected cytarabine (Ara-C)/dexamethasone (DEXA) into the spinal column at day 190. High-dose Ara-C therapy was performed from days 202 to 204. We actively treated the patient, but he died on day 220. HD hemodialysis, CHDF continuous hemodiafiltration, RB renal biopsy, Cr creatinine, LDH lactate dehydrogenase, sIL-2R soluble interleukin-2 receptor, UV urinary volume the time of diagnosis is associated with a particularly poor prognosis, in part because of the high incidence of CNS involvement [11] . Although the mechanism of dissemination of lymphoma into the CNS remains unclear, the expression of certain genes and adhesion molecules on the surface of non-Hodgkin's lymphoma cells has been associated with a tendency towards extranodal involvement, tumor aggressiveness, and poorer outcomes [11, 12] . Current strategies to prevent CNS relapse in patients with renal involvement, including the use of rituximab, are generally ineffective. A previous report demonstrated that renal involvement is an independent risk factor for CNS relapse in patients with DLBCL in both the pre-and post-rituximab treatment eras [13] .
Renal infiltration of DLBCL is considered a secondary process, and is thought to be a feature of progressive disease. Given the association of renal involvement with CNS relapse, the early evaluation of the CNS, for example with spinal fluid testing, is important in this patient population.
Conclusion
Herein, we reported a patient with AKI because of DLBCL infiltration of the bilateral kidneys. Although tumor size and renal function rapidly improved with R-CHOP therapy, the patient ultimately died from CNS relapse. The kidneys were serially biopsied (at the time of diagnosis, following R-CHOP chemotherapy, and during autopsy). Serial biopsies allowed us to make the initial diagnosis, document improvement after chemotherapy, and identify renal recurrence after CNS relapse. We believe that this is the first report of three serial renal biopsies performed in a patient with DLBCL presenting with AKI. f Specimens obtained during autopsy demonstrating diffuse CD20-positive lymphocyte infiltration. CD20 stain, magnification 940 (large windows) and 9400 (small windows)
